Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/1989
08/10/1989WO1989006974A2 T-cell epitope as carriers molecule for conjugate vaccines
08/10/1989WO1989006968A1 Therapeutic use of anti-t cell immunotoxin for autoimmune diseases
08/10/1989WO1989006967A1 Immunosupression with anti-pan t-cell immunotoxin compositions
08/10/1989WO1989006964A1 Ophthalmic suspensions
08/10/1989WO1989006962A1 Silver sulfadiazine-containing agent for topical external therapy
08/10/1989WO1989006959A1 Pharmaceutical composition having improved releasability
08/09/1989EP0327505A2 Polymeric materials made from destructurized starch and at least one synthetic thermoplastic polymeric material
08/09/1989EP0327389A2 Tumour imaging
08/09/1989EP0327327A2 Medicated cleansing pads
08/09/1989EP0327326A1 Medicated cleansing pads
08/09/1989EP0327280A1 Cyclosporin compositions
08/09/1989EP0327263A1 Hair growth stimulation with nitroxide and other radicals
08/09/1989EP0327169A2 Immunotoxins from barley toxin
08/09/1989EP0327086A2 Multi-layer granule
08/09/1989EP0327070A1 Fluorocarbon chain-containing antigenic conjugates
08/09/1989EP0326829A2 Synergetic antioxidant mixture
08/09/1989EP0326618A1 Medicinal composition containing albumin as carrier and process for its preparation
08/09/1989EP0326550A1 Method for utilizing an exocellular polysaccharide isolated from zoogloea ramigera
08/09/1989CN1034581A Antigen-antibody conjugate
08/09/1989CN1034543A Antibody conjugates
08/08/1989US4855353 High molecular compounds having amino groups, and their utilization
08/08/1989US4855326 Rapidly dissoluble medicinal dosage unit and method of manufacture
08/08/1989US4855307 Treatment of psychotic disorders
08/08/1989US4855294 Containing glycerin
08/08/1989US4855142 Pharmaceutical plaster
08/08/1989CA1258229A1 Amphipathic peptides
08/08/1989CA1258226A1 Method of producing standarized iodophor preparations and such preparations
08/02/1989EP0326407A2 Method for preparing aqueous analytical reagents containing water insoluble antioxidant
08/02/1989EP0326322A1 Antibody conjugates
08/02/1989EP0326278A1 Method for the manufacture of drug permeable materials
08/02/1989EP0326196A2 Aqueous pharmaceutical preparation
08/02/1989EP0326155A2 Polyaluminum dialkyl phosphate, oil gelling agent comprising the same, and composition for external application comprising the same
08/02/1989EP0326151A2 Improved controlled release formulation
08/02/1989EP0326145A1 Agent containing silver sulphadiazine for local external therapy
08/02/1989EP0326103A1 Pharmaceutical composition for 4-aroylimidazol-2-ones
08/02/1989EP0326026A2 Stable mixture containing oxidation-sensitive compounds, process to obtain it and use of a combination of products to stabilize oxidation-sensitive compounds
08/02/1989EP0325949A1 Concentrated solutions of corticosteroids and method of making them
08/02/1989EP0325628A1 Agent containing salicylic acid for treating lepidosis
08/02/1989EP0162781B1 Conjugates associated with a covalent bond to a monovalent carboxylic ionophore and a macromolecule, their use as potentializers of immunotoxines and the activated intermediate ionophores
08/02/1989CN1034311A Freeze drying preparation for compound of platinum
08/01/1989US4853464 Hybridoma cell line XMMBR-B14 and monoclonal antibody which is specific for a non-cross reactive epitope of CEA
08/01/1989US4853430 Polyesterether copolymers comprising dimerized fatty acid and polyalkylene oxide endcapped with fatty acid
08/01/1989US4853416 Solutions of pentamidine
08/01/1989US4853388 Applying 5-fluoroacyl dissolved in penetration enhancer;
08/01/1989US4853379 Stable hydrocortisone-based composition for use in local corticotherapy
08/01/1989US4853374 Viscoelastic vitreous substitute with UV blocker
08/01/1989US4853372 Non-aqueous ivermectin formulation with improved antiparasitic activity
08/01/1989US4853247 Oil soluble sensory agent to cover up unpleasant oil
08/01/1989US4853226 Sustained-release particulate preparation and process for preparing the same
08/01/1989US4853225 Process for implanting a medicament depot
07/1989
07/27/1989WO1989006692A1 Method of treating tumor cells by inhibiting growth factor receptor function
07/27/1989WO1989006546A1 Conjugation of polymer to colony stimulating factor-1
07/27/1989WO1989006540A1 Diabetic control by combined insulin forms
07/27/1989WO1989006537A1 Topical metronidazole formulations and therapeutic uses thereof
07/27/1989WO1989006536A1 Growth inhibiting agent and the use thereof
07/26/1989EP0325270A2 Anticancer conjugates
07/26/1989EP0325244A1 Aqueous solution of fat-soluble substance
07/26/1989EP0325199A2 Fumagillin as angiostatic agent
07/26/1989EP0325113A1 Stabilised dried preparation containing cytostatic anthracyclin antibiotics, and processes for preparing them
07/26/1989EP0325112A1 Stabilization of cephalosporin derivatives by drying with a stabilizer, and stable preparations containing cephalosporin derivatives
07/26/1989EP0325086A2 Novel methods for obtaining therapeutic systems with controlled release of the drug
07/26/1989EP0324982A1 Inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrin, a process for preparing the same and a sustained release pharmaceutical preparation containing the same
07/26/1989CN1034132A Aqueous formulation containing piperidinylcyclopentylheptenoic acid derivative
07/26/1989CN1034131A Antibacterial lyophilized prepn.
07/25/1989US4851560 Inositol triphosphates
07/25/1989US4851543 And polyvinylpyrrolidone-halogen complex
07/25/1989US4851521 Esters of hyaluronic acid
07/25/1989US4851442 Antiarthritic, antiinflammatory, analgesic, antiswelling
07/25/1989US4851435 Containing anionic adjuvant with lipophilic and hydrophilic groups for increased activity
07/25/1989US4851434 Amide of di-, tri- or polyglycol or glucamine reaction product with d-hydroxy acid
07/25/1989US4851393 Method for utilizing an exocellular polysaccharide isolated from zoogloea ramigera
07/25/1989US4851391 5-ethyl-2-deoxyuridine and urea composition for the treatment of viral diseases
07/25/1989US4851339 Dyes from plants
07/25/1989US4851220 Water in oil emulsions; sustained release, drug injections
07/25/1989CA1257837A1 Topical pharmaceutical compositions
07/19/1989EP0324625A1 Antigen antibody conjugate
07/18/1989US4849509 Hybridomas
07/18/1989US4849451 Fat emulsion containing prostaglandin
07/18/1989US4849426 Method for treating actinic keratosis with cytotoxic agents
07/18/1989US4849425 Readily absorbable pharmaceutical composition
07/18/1989US4849418 Transdermally absorbable water-containing preparations of arylpropionic acid derivatives and process for preparing same
07/18/1989US4849228 Polymer, production and use thereof
07/18/1989US4849225 Process to prepare solid products containing oil-soluble substance
07/18/1989US4849222 Psyllium gum, polyol polyester
07/18/1989CA1257727A1 Hydrophilic silicone-organic copolymer elastomers
07/18/1989CA1257601A1 Coupling agents for radiolabeled antibody fragments
07/13/1989WO1989006138A1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES
07/13/1989WO1989006134A1 Pharmaceutical preparation for treating immunodeficiency conditions
07/13/1989DE3843059A1 Aqueous formulations which contain a piperidinylcyclopentylheptenoic acid derivative
07/13/1989DE3744518A1 Ferromagnetic antibodies for contrast enhancement of in vivo magnetic resonance imaging
07/12/1989EP0323494A1 Lecithin gel
07/11/1989US4847325 Conjugation of polymer to colony stimulating factor-1
07/11/1989US4847298 Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments
07/11/1989US4847283 Ointment and method for treating skin lesions due to herpes virus
07/11/1989US4847260 Composition for percutaneous administration
07/11/1989US4847250 Pyroglutamic acid esters used as dermal penetration enhancers for drugs
07/11/1989US4847240 Cationic polymers as transport carriers
07/11/1989US4847151 Electric conductor covered by covering material
07/11/1989US4847091 Pharmaceutical composition including sodium cromoglycate
07/11/1989US4847080 Genetic engineering
1 ... 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 ... 1712